Letter to the Editor: Glaucoma Surgery During the COVID-19 Pandemic in Italy: How Novel Coronavirus Has Changed the Surgical Management of Glaucoma Patients

Krishna, Umesh; Venkatesh, Rengaraj; Srinivasan, Kavitha; Odayappan, Annamalai; Robin, Alan L.

doi:10.1097/ijg.0000000000001810

Cited by 2 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As more data become available supporting the efficacy of selective laser trabeculoplasty, microinvasive glaucoma surgery, and sustained drug delivery devices, glaucoma specialists may shift their practice patterns toward earlier intervention to mitigate such adverse outcomes. Interestingly, reports from countries including India, Italy, and the United Kingdom have demonstrated a significant decrease in the number of trabeculectomies performed during the pandemic in favor of less invasive procedures, including cyclophotocoagulation and microinvasive glaucoma surgery [76 ▪ –79 ▪ ]. The pandemic's influence on surgical trends in the United States has yet to be formally evaluated.…”

Section: Discussionmentioning

confidence: 99%

How glaucoma care changed for the better after the pandemic

Vinod

Sidoti

2021

Current Opinion in Ophthalmology

View full text Add to dashboard Cite

Purpose of review The current article reviews enhancements to the delivery of glaucoma care that developed in response to the coronavirus disease 19 (COVID-19) pandemic and are likely to persist beyond its resolution. Recent findings Literature from the review period (2020–2021) includes reports highlighting contributions of the ophthalmology community to global health during the pandemic. Glaucoma practices worldwide have instituted more robust infection control measures to mitigate severe acute respiratory syndrome coronavirus 2 transmission in the outpatient setting, and many of these modifications will endure in the post-COVID era. Operational adjustments have led to the provision of more efficient glaucoma care. A hybrid care model involving technician-based diagnostic testing and subsequent virtual consultation with a glaucoma specialist has evolved as a useful adjunct to traditional face-to-face encounters with patients. Summary Glaucoma specialists, patients, and staff have adapted to a ‘new normal’ of glaucoma care delivery during the COVID-19 pandemic. Although innovation has propelled several improvements to glaucoma care during this global health crisis, significant barriers to more widespread implementation of teleglaucoma still exist. Whether, and in what capacity, the pandemic has permanently altered glaucoma practice patterns remains to be seen.

show abstract

Section: Discussionmentioning

confidence: 99%

How glaucoma care changed for the better after the pandemic

Vinod

Sidoti

2021

Current Opinion in Ophthalmology

View full text Add to dashboard Cite

show abstract

“…However, the number of intravitreal injections performed during the pandemic dropped around the world (2,10). A study performed in three hospitals in the United States (in New York, Boston, and Miami) reported a decrease in the number of intravitreal injections compared with the same period in the previous year of 30%-64% (14 (24). Research conducted in 39 hospitals in Italy determined a 73% decrease in trabeculectomies, a 59% in glaucoma drainage implants, and an 85% decrease in cyclophotocoagulation in the March 10-May 9, 2020, lockdown period compared with the same period in 2019 (25).…”

mentioning

confidence: 99%

Changes in the Prevalence of Neovascular Glaucoma in Individuals Over Sixty-Five Years of Age During the Covid-19 Pandemic

Satici

2022

Harran Üniversitesi Tıp Fakültesi Dergisi

View full text Add to dashboard Cite

Amaç: Pandeminin farklı dönemlerinde 3. basamak bir hastaneye başvuran 65 yaş üstü neovasküler glokomlu olguların sayısında, GİB’ ı ve görme düzeylerindeki değişikliği incelemeyi amaçlamaktadır. Materyal ve metod: Hastalar karantina öncesi (21 mart 2019 -10 haziran 2019), karantina dönemi (21 mart 2020 -10 haziran 2020), karantina sonrası (21 mart 2021 -10 haziran 2021) 65 yaş üstü neovasküler glokom tanılı hastalar olmak üzere 3 gruba ayrıldı. Yaş, cinsiyet, dahil olan göz(ler), etiyoloji, göz içi basıncı (GİB), en iyi düzeltilmiş görme keskinliği (EİDGK), uygulanan tedaviler karşılaştırıldı. Bulgular: Karantina öncesi gruba göre karantina grubunda % 51.02, karantina sonrası grubunda % 14.29 oranında hasta sayısında azalma tespit ettik. Karantina döneminde uygulanan tedavi sayısı, karantina öncesi döneme göre % 51.85 azaldı (p=0.002). Karantina ve karantina sonrası dönem, karantina öncesi ile karşılaştırıldığında ortalama EİDGK seviyelerinde istatiksel anlamlı fark saptanmadı (p=0.078). Ancak ortalama GİB değerlerinde anlamlı fark tespit edildi (p<0.001) Sonuç: 65 yaş üstü neovasküler glokomlu hastaların karantina sürecinde ve sonrasında hastaneye başvurularında azalma tespit edildi. Karantina sürecinden sonra tedavinin gecikmesine bağlı olarak görme düzeylerinde azalma, GİB seviyelerinde yükselme mevcut idi. İlerleyen dönemlerde kaçınılmaz olarak neovasküler glokomlu hasta ve cerrahi sayısında artış görülecektir.

show abstract

Letter to the Editor: Glaucoma Surgery During the COVID-19 Pandemic in Italy: How Novel Coronavirus Has Changed the Surgical Management of Glaucoma Patients

Cited by 2 publications

References 4 publications

How glaucoma care changed for the better after the pandemic

How glaucoma care changed for the better after the pandemic

Changes in the Prevalence of Neovascular Glaucoma in Individuals Over Sixty-Five Years of Age During the Covid-19 Pandemic

Contact Info

Product

Resources

About